The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
RETRACTED: Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway
Open accessAbstract
Objectives: Tanshinone I (Tan‐I) is one of the vital fatsoluble monomer components, which extracted from Chinese medicinal herb Salvia miltiorrhiza Bunge. It has been shown that Tan‐I exhibited anti‐tumour activities on different types of cancers. However, the underlying mechanisms by which Tan‐Ⅰ regulates apoptosis and autophagy in ovarian cancer remain unclear. Thus, this study aimed to access the therapy effect of Tan‐Ⅰ and the underlying mechanisms. Methods: Ovarian cancer cells A2780 and ID‐8 were treated with different concentrations of Tan‐Ⅰ (0, 1.2, 2.4, 4.8 and 9.6 μg/mL) for 24 hours. The cell proliferation was analysed by CCK8 assay, EdU staining and clone formation assay. Apoptosis was assessed by the TUNEL assay and flow cytometry. The protein levels of apoptosis protein (Caspase‐3), autophagy protein (Beclin1, ATG7, p62 and LC3II/LC3I) and PI3K/AKT/mTOR pathway were determined by Western blot. Autophagic vacuoles in cells were observed with LC3 dyeing using confocal fluorescent microscopy. Anti‐tumour activity of Tan‐Ⅰ was accessed by subcutaneous xeno‐transplanted tumour model of human ovarian cancer in nude mice. The Ki67, Caspase‐3 level and apoptosis level were analysed by immunohistochemistry and TUNEL staining. Results: Tan‐Ⅰ inhibited the proliferation of ovarian cancer cells A2780 and ID‐8 in a dose‐dependent manner, based on CCK8 assay, EdU staining and clone formation assay. In additional, Tan‐Ⅰ induced cancer cell apoptosis and autophagy in a dose‐dependent manner in ovarian cancer cells by TUNEL assay, flow cytometry and Western blot. Tan‐Ⅰ significantly inhibited tumour growth by inducing cell apoptosis and autophagy. Mechanistically, Tan‐Ⅰ activated apoptosis‐associated protein Caspase‐3 cleavage to promote cell apoptosis and inhibited PI3K/AKT/mTOR pathway to induce autophagy. Conclusions: This is the first evidence that Tan‐Ⅰ induced apoptosis and promoted autophagy via the inactivation of PI3K/AKT/mTOR pathway on ovarian cancer and further inhibited tumour growth, which might be considered as effective strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Fan, N., Gao, J.-L., Liu, Y., Song, W., Zhang, Z.-Y., & Gao, C. (2015) · BioMed Research International · doi:10.1155/2015/365068 · Cited by 22
RetractedSiegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Self-citationAutophagy in cell death: an innocent convict?
Levine, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26390 · Cited by 1,676
Autophagy in mammalian development and differentiation
Mizushima, N., & Levine, B. (2010) · Nature Cell Biology · doi:10.1038/ncb0910-823 · Cited by 1,555
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Lheureux, S., Braunstein, M., & Oza, A. M. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21559 · Cited by 1,423
Yu, J. S. L., & Cui, W. (2016) · Development · doi:10.1242/dev.137075 · Cited by 1,135
Heras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J., & Pedraza-Chaverri, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.019 · Cited by 1,091
Epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.08.006 · Cited by 995
Autophagy as a target for anticancer therapy
Janku, F., McConkey, D. J., Hong, D. S., & Kurzrock, R. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.71 · Cited by 803
Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
Polivka, J., & Janku, F. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.12.004 · Cited by 765
Autosis and autophagic cell death: the dark side of autophagy
Liu, Y., & Levine, B. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.143 · Cited by 742
PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
O’Donnell, J. S., Massi, D., Teng, M. W. L., & Mandala, M. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.015 · Cited by 375
Nuclear export of proteins and drug resistance in cancer
Turner, J. G., Dawson, J., & Sullivan, D. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.016 · Cited by 350
Epidemiology of Ovarian Cancer
Permuth-Wey, J., & Sellers, T. A. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-492-0_20 · Cited by 326
Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy
Fulda, S., & Kögel, D. (2015) · Oncogene · doi:10.1038/onc.2014.458 · Cited by 307
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
Zhang, Y., Jiang, P., Ye, M., Kim, S.-H., Jiang, C., & Lü, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131013621 · Cited by 257
Targeting PI3K/AKT/mTOR network for treatment of leukemia
Bertacchini, J., Heidari, N., Mediani, L., Capitani, S., Shahjahani, M., Ahmadzadeh, A., & Saki, N. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1867-5 · Cited by 243
Potential anticancer activity of tanshinone IIA against human breast cancer
Wang, X., Wei, Y., Yuan, S., Liu, G., Lu, Y., Zhang, J., & Wang, W. (2005) · International Journal of Cancer · doi:10.1002/ijc.20880 · Cited by 237
Borrie, S. C., Brems, H., Legius, E., & Bagni, C. (2017) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035332 · Cited by 165
Efferth, T., Kahl, S., Paulus, K., Adams, M., Rauh, R., Boechzelt, H., Hao, X., Kaina, B., & Bauer, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0073 · Cited by 142
PLC and PI3K/Akt/mTOR signalling in disease and cancer
Follo, M. Y., Manzoli, L., Poli, A., McCubrey, J. A., & Cocco, L. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.10.004 · Cited by 127
Anticancer effects of tanshinone I in human non-small cell lung cancer
Lee, C.-Y., Sher, H.-F., Chen, H., Liu, C.-C., Chen, C., Lin, C., Yang, P., Tsay, H.-S., & Chen, J. J. W. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2288 · Cited by 126
Self-citationRole of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells
Roy, B., Pattanaik, A. K., Das, J., Bhutia, S. K., Behera, B., Singh, P., & Maiti, T. K. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.01.003 · Cited by 111
Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents
Sun, H. Y., Wang, Z., & Yakisich, J. S. (2013) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990130 · Cited by 107
Chen, W., Luo, Y., Liu, L., Zhou, H., Xu, B., Han, X., Shen, T., Liu, Z., Lu, Y., & Huang, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0020 · Cited by 104
Cheng, X., Ma, X., Ding, X., Li, L., Jiang, X. M., Shen, Z., Chen, S., Liu, W., Gong, W., & Sun, Q. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.010 · Cited by 102
Nizamutdinova (1992) · International Journal of Oncology · doi:10.3892/ijo_00000031 · Cited by 99
Zhang, Y., Wei, L., Sun, D., Cao, F., Gao, H., Zhao, L., Du, J., Li, Y., & Wang, H. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01166.x · Cited by 96
Recent insights into the biological activities and drug delivery systems of tanshinones
Chen, M., Cai, Y., Zhang, W., Chen, Z., Shi, Z., & He, C. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s84035 · Cited by 86
Autophagy in cancer: a complex relationship
Wilde, L. R., Tanson, K., Curry, J., & Martinez‐Outschoorn, U. (2018) · Biochemical Journal · doi:10.1042/bcj20170847 · Cited by 62
Growth inhibition and apoptosis induction by tanshinone I in human colon cancer Colo 205 cells
Su, C. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000063 · Cited by 61
PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy
Fan, S., Zhang, B., Luan, P., Gu, B., Wan, Q., Huang, X., Liao, W., & Liu, J. (2015) · BioMed Research International · doi:10.1155/2015/161020 · Cited by 61
Synthetic lethality by co-targeting mitochondrial apoptosis and PI3K/Akt/mTOR signaling
Fulda, S. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.04.011 · Cited by 58
Wang, W., Li, J., Ding, Z., Li, Y., Wang, J., Chen, S., & Miao, J. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14539 · Cited by 57
Su, C., & Chiu, T. (2016) · Oncology Reports · doi:10.3892/or.2016.4857 · Cited by 54
Tanshinone I alleviates insulin resistance in type 2 diabetes mellitus rats through IRS-1 pathway
Wei, Y., Gao, J., Qin, L., Xu, Y., Dongchao, W., Shi, H., Xu, T., & Liu, T. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.040 · Cited by 53
Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers
Jing, X., Xu, Y., Cheng, W., Guo, S., Ya, Z., & Li, H. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3034-6 · Cited by 50
Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice
Tang, Y., Chen, Y., Chu, Z., Yan, B., & Xu, L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.019 · Cited by 40
Lu, M., Wang, C., & Wang, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3565 · Cited by 36
Kim, M. K., Park, G. H., Eo, H. J., Song, H. M., Lee, J. W., Kwon, M. J., Koo, J. S., & Jeong, J. B. (2015) · Fitoterapia · doi:10.1016/j.fitote.2015.01.010 · Cited by 32
Caspase-3-mediated cleavage of PICOT in apoptosis
Yun, N., Kim, C., Cha, H., Park, W. J., Shibayama, H., Park, I., & Oh, Y. J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.017 · Cited by 26
L’autophagie : le yin et le yang des cancers
Joffre, C., Djavaheri‐Mergny, M., Pattingre, S., & Giuriato, S. (2017) · médecine/sciences · doi:10.1051/medsci/20173303021 · Cited by 24
Chen, G., Liang, Y., Liang, X., Li, Q., & Liu, D.-L. (2015) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000000544 · Cited by 18
Cited by
Zhu, Y., Ouyang, Z., Du, H., Wang, M., Wang, J., Sun, H., Kong, L., Xu, Q., Ma, H., & Sun, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.022 · Cited by 414
Chen, G., Zhang, H., Sun, H., Ding, X., Liu, G., Yang, F., Feng, G., Dong, X., Zhu, Y., Wang, X., et al. (2023) · Apoptosis · doi:10.1007/s10495-023-01855-z · Cited by 47
Recent advances of tanshinone in regulating autophagy for medicinal research
Wu, S., Zhao, K., Wang, J., Liu, N., Nie, K., Qi, L., & Xia, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059360 · Cited by 32
Metadata
- Authors
- Zhou, J., Jiang, Y., Chen, H., Wu, Y., & Zhang, L.
- Venue
- Cell Proliferation
- Publisher
- Wiley
- Published
- 2019-12-09
- Volume
- 53
- Issue
- 2
- Pages
- e12739-e12739
- ISSN
- 0960-7722 (ISSN-L)
- 1365-2184
- OpenAlex
- W2995859967
- Cited by
- 322
- References
- 44
- FWCI
- 29.75
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.